Crucell NV Company Profile Complimentary D&B Business Overview on over 38 million companies with Free Registration!

Crucell NV

Archimedesweg 4
Leiden, 2333-CN
Netherlands
URL: http://www.crucell.com/
Primary Symbols & Exchanges:
CRXL - Euronext Amsterdam
CRXL - NASDAQ
- Pink Sheets
- SWX Swiss Exchange
Primary Industry:
Business Services
SIC Industry Code:
Thomson Financial Business Description:
The Group's principal activities are developing, producing and marketing vaccines and antibodies against infectious diseases for private and public markets worldwide. The Group operates in three main markets: paediatric, travel and endemic and respiratory. Paediatric products include Quinvaxem, Epaxal, Hepavax-Gene and MoRu-Viraten. Travel and endemic products include Epaxal, Vivotif and Dukoral. Respiratory product includes Inflexal. The Group's research and development focusses on influenza, tubercolosis and malaria vaccine, rabies monocial antibody cocktail, ebola, HIV and yellow fever vaccine. The Group uses five technologies: PER.C6, AdVac, MAbstract, STAR and Virosome. The Group markets its products in 60 countries.
Alacra Alerts: Crucell NV RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on Crucell NV

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:







Search for more premium content on Crucell NV
  about us contact us public company index private company index pcan widget your privacy rights terms & conditions